Agreement Between Guideline Thresholds Using an “All‐in‐One” Device to Measure Office, Home, and Ambulatory Blood Pressures Authors: Kazuomi Kario, Naoko Tomitani, Satoshi Hoshide, Masafumi Nishizawa, Tetsuro Yoshida, Tomoyuki Kabutoya, Takeshi Fujiwara, Hiroyuki Mizuno, the HI‐JAMP Study Group Published: 2023 ABSTRACT BackgroundBlood pressure (BP) thresholds for diagnosing and managing hypertension vary for office, home, and ambulatory readings, and between guideline documents. This analysis determined corresponding office, home, and ambulatory BP thresholds using baseline data from the HI‐JAMP (Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective) study, which used a validated “all‐in‐one” BP monitoring device.Methods and ResultsData from 2322 treated patients with hypertension who underwent office BP measurement, then 24‐hour ambulatory BP monitoring, then home BP monitoring for 5 days were analyzed. Corresponding BP thresholds for office, home, and ambulatory measurements were determined using Deming regression. Values equivalent to office systolic BP (SBP) of 120 and 140 mm Hg were as follows: 115.9 and 127.7 mm Hg for 24‐hour ambulatory SBP; 120.8 and 134.0 mm Hg for daytime ambulatory SBP; 104.9 and 117.9 mm Hg for nighttime ambulatory SBP; and 122.0 and 134.2 mm Hg for morning‐evening average home SBP. Deming regression showed that morning‐evening average home SBP and daytime ambulatory SBP were almost the same (home SBP=0.99×daytime ambulatory SBP+0.27 mm Hg; r=0.627). Morning‐evening average home SBP values of 120 and 135 mm Hg were equivalent to daytime ambulatory SBP values of 119.1 and 133.9 mm Hg, respectively. A home SBP threshold of 130 mm Hg corresponded to 24‐hour and nighttime ambulatory SBP values of 123.5 and 113.6 mm Hg, whereas a home SBP threshold of 135 mm Hg corresponded to 24‐hour and nighttime ambulatory SBP values of 128.0 and 119.2 mm Hg.ConclusionsAmbulatory and home BP thresholds in this analysis were similar to those proposed by existing guidelines. The similarity between the home BP and daytime ambulatory BP thresholds was a clinically relevant finding. Nonstandard Abbreviations and Acronyms ambulatory blood pressure monitoring American College of Cardiology/American Heart Association diastolic blood pressure home blood pressure monitoring Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective morning‐evening systolic blood pressure Clinical PerspectiveWhat Is New? This study is the first to use an all‐in‐one blood pressure (BP) monitoring device to obtain values for office, home, and ambulatory BP, and determine corresponding thresholds for these different types of BP measurement.In this population of Japanese patients with treated hypertension, thresholds for office, home, and ambulatory BP measurements, determined using the same device, showed good agreement with current US and Japanese hypertension guideline BP thresholds. What Are the Clinical Implications? These data highlight the value and reliability of home BP monitoring–based approaches to hypertension diagnosis and management.The identified BP thresholds can be used to help define diagnostic and therapeutic BP levels for a home BP‐guided digital approach to hypertension management. Clinical Perspective What Is New? This study is the first to use an all‐in‐one blood pressure (BP) monitoring device to obtain values for office, home, and ambulatory BP, and determine corresponding thresholds for these different types of BP measurement.In this population of Japanese patients with treated hypertension, thresholds for office, home, and ambulatory BP measurements, determined using the same device, showed good agreement with current US and Japanese hypertension guideline BP thresholds. This study is the first to use an all‐in‐one blood pressure (BP) monitoring device to obtain values for office, home, and ambulatory BP, and determine corresponding thresholds for these different types of BP measurement. This study is the first to use an all‐in‐one blood pressure (BP) monitoring device to obtain values for office, home, and ambulatory BP, and determine corresponding thresholds for these different types of BP measurement. In this population of Japanese patients with treated hypertension, thresholds for office, home, and ambulatory BP measurements, determined using the same device, showed good agreement with current US and Japanese hypertension guideline BP thresholds. In this population of Japanese patients with treated hypertension, thresholds for office, home, and ambulatory BP measurements, determined using the same device, showed good agreement with current US and Japanese hypertension guideline BP thresholds. What Are the Clinical Implications? These data highlight the value and reliability of home BP monitoring–based approaches to hypertension diagnosis and management.The identified BP thresholds can be used to help define diagnostic and therapeutic BP levels for a home BP‐guided digital approach to hypertension management. These data highlight the value and reliability of home BP monitoring–based approaches to hypertension diagnosis and management. These data highlight the value and reliability of home BP monitoring–based approaches to hypertension diagnosis and management. The identified BP thresholds can be used to help define diagnostic and therapeutic BP levels for a home BP‐guided digital approach to hypertension management. The identified BP thresholds can be used to help define diagnostic and therapeutic BP levels for a home BP‐guided digital approach to hypertension management. Defined blood pressure (BP) thresholds are essential to allow effective and consistent diagnosis of hypertension and for monitoring the effects of interventions to reduce BP. Historically, clinical decisions were based on office (clinic) BP values alone. However, the past decade has seen increased recognition of the importance of out‐of‐office BP monitoring in the diagnosis and treatment of hypertension. 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 Out‐of‐office BP measurements have consistently been shown to provide better information about cardiovascular prognosis than office BP. 9 , 10 , 11 , 12 In addition, it has recently been reported that home BP was superior to ambulatory BP in terms of predicting cardiovascular prognosis. 13 These data support current guideline recommendations for the use of ambulatory and home BP monitoring (ABPM and HBPM, respectively) for the diagnosis and management of hypertension. 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 In particular, home BP thresholds are likely to become increasingly relevant in an era that is seeing increasing use of home‐based digital strategies for hypertension evaluation and treatment. 14 , 15 Furthermore, just the act of self‐measurement of home BP with telemonitoring has been shown to reduce BP and increase the proportion of patients with BP normalization. 16 BP thresholds for home and ambulatory measurements differ from those for office BP and vary between different international guidelines (Table S1). 4 , 5 , 6 , 7 , 8 As the use of ABPM and HBPM increases, clear and correct definition of BP thresholds that correspond to office BP is important. However, there are currently no data on the corresponding thresholds of office, home, and ambulatory BP determined using the same BP measurement device. Therefore, this study used baseline data from the HI‐JAMP (Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective) study to determine corresponding values for office, home, and ambulatory BP measured using the same device in treated patients with hypertension. METHODS The data that support the findings of this study are available from the corresponding author upon reasonable request. Study Design The HI‐JAMP study (University Hospital Medical Information Network trials registration: UMIN000029151) is a Japanese, nationwide, multicenter, general practitioner–based, prospective trial that has 2 key aims. The first is to investigate the ability of different BP parameters (office BP, home BP, and ambulatory BP) obtained by a single all‐in‐one BP monitoring device (TM‐2441; A&D Co, Tokyo, Japan) to predict cardiovascular events, and the second is to investigate relationships between BP parameters and individual environmental (temperature and atmospheric pressure) and lifestyle (physical activity) factors for which data are obtained by sensors incorporated into the BP monitoring device. 17 After approval of the study protocol by the Jichi Medical University Bioethics Committee for Medical Research (Tochigi, Japan), the study was started in 2017. Recruitment was completed in 2020, and annual follow‐up will continue until March 31, 2026. 17 , 18 All participants provided written informed consent. Study Population Full details of patient inclusion and exclusion criteria for the HI‐JAMP study have been reported previously. 17 Briefly, patients were aged ≥20 years, had hypertension, and were being treated with antihypertensive drug therapy. Those with cerebrovascular disease within the previous 6 months (except for asymptomatic disease or transient ischemic attack), those requiring hemodialysis, those with clinically overt dementia, and those with cancer or with connective tissue disease were excluded. Of the participants enrolled in the HI‐JAMP study, those who completed office, home, and ambulatory BP monitoring were included in the current analysis. BP Monitoring A single information and communication technology–based multisensory ABPM device, which can also be used as an HBPM device (TM‐2441; A&D Company, Tokyo, Japan), was used in the HI‐JAMP study, as previously described in detail. 17 This device can be used for both manual measurement of BP (ie, office BP and home BP) and automated measurement of BP (ie, ambulatory BP and automated office BP) at the upper arm. It has been validated in accordance with the ISO81060‐147 2:2013 protocol. 19 Office BP was measured on study day 1, followed by 24‐hour ambulatory BP monitoring (ABPM; day 1 to day 2), and then 5 days of HBPM starting with an evening measurement on day 2 and concluding with a morning measurement on day 7. Some patients took home BP measurements for >5 days when they were asked to. To avoid bias attributable to the number of measurements, home BP data for no more than 7 days were extracted and used for the analysis. The BP measurement device was placed on the nondominant arm using an appropriately sized cuff. Two measurements were taken to determine office BP. “Office BP” index was defined as the average of these 2 readings at 1 visit. During ABPM, readings were taken automatically at 30‐minute intervals over 24 hours. Participants reported their sleep and wake times in a diary. Nighttime readings were defined as those taken from the self‐reported time of falling asleep to the self‐reported time of waking, and all other readings were defined as daytime readings. BP readings during the 24‐hour, daytime, and nighttime periods were averaged to obtain the “24‐hour average,” “daytime,” and “nighttime ambulatory BP,” respectively. For home BP, 2 measurements were taken at each time point; morning measurements were taken within 1 hour after waking, and evening measurements were taken before going to bed. The “morning home average” and “evening home average” were defined as the average of home BP measured in the morning and evening, respectively. The “morning‐evening (ME) average” was calculated by averaging the mean values of the morning and evening home BP readings taken on the same day. Statistical Analysis Associations between office, home, and ambulatory BP measurements were visualized using scatterplots. Each plot represents the value of each BP index measured at baseline for 1 subject (office, home, and ambulatory BP measurements that were recorded consecutively between day 1 and day 7). Deming regression, an error‐in‐variables regression method that accounts for errors in the dependent and independent variables, 20 was used to create a prediction equation for the dependent variable using the independent variable. Nonconstant Deming regression was also generated for the same comparisons without a constant. A restricted cubic spline regression was developed to consider nonlinear relationships. All analyses were conducted using the SAS software program, version 9.4 (SAS Institute, Cary, NC) and R, version 4.2.3. RESULTS Study Population A total of 2754 patients were enrolled into the HI‐JAMP study between 2017 and 2020, of whom 2731 were included in the final analysis. 17 Complete baseline BP data were available for 2322 patients (mean±SD age, 69.2±11.5 years; mean±SD body mass index, 24.9±4.1 kg/m2; 53% men), all of whom were included in the current analysis (Table S2). Hyperlipidemia was the most common comorbidity (52% of patients), followed by hyperuricemia, atrial fibrillation, and chronic kidney disease (in 12%–13% of patients each) (Table S2). BP Readings Recorded by a Single All‐in‐One BP Monitoring Device Average office systolic BP (SBP)/diastolic BP (DBP) was 132.8/81.7 mm Hg, calculated from an average of 1.6±0.5 measurements (Table S3). A total of 44.3±3.8 measurements were obtained from the ABPM device during a 24‐hour period. The 24‐hour average BP, daytime BP, and nighttime BP values were 123.8/75.2, 128.7/78.4, and 113.8/69.0 mm Hg, respectively. The number of HBPM readings obtained over 6.5±1.0 days was 21.0±4.6. ME average BP, morning home BP, and evening home BP values were 129.8/78.2, 134.3/81.1, and 126.1/75.7 mm Hg, respectively. Office Versus Ambulatory BP Statistically significant linear relationships were documented between office SBP and 24‐hour average SBP, daytime SBP, and nighttime SBP (Figure 1) and between office DBP and 24‐hour average DBP, daytime DBP, and nighttime DBP (Figure S1). A prediction equation using Deming regression was developed to calculate the specific values for ambulatory BP parameters that correspond to different office BP values; these are shown in the tables below each graph in Figure 1 (SBP) and Figure S1 (DBP). Deming regression between office SBP and ambulatory SBP (A, 24‐hour average; B, daytime; and C, nighttime). Each horizontal line indicates the ambulatory SBP value corresponding to an office SBP value in the same color based on the 2017 ACC/AHA guidelines. Red lines indicate office SBP: 80 mm Hg; 24‐hour average SBP: 75 mm Hg; daytime SBP: 80 mm Hg; and nighttime SBP: 65 mm Hg. Blue lines indicate office SBP: 90 mm Hg; 24‐hour average SBP: 80 mm Hg; daytime SBP: 85 mm Hg; and nighttime SBP: 70 mm Hg. Green lines indicate office SBP: 100 mm Hg; 24‐hour average SBP: 90 mm Hg; daytime SBP: 90 mm Hg; and nighttime SBP: 85 mm Hg. *P<0.001. ACC indicates American College of Cardiology; AHA, American Heart Association; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; and SBP, systolic blood pressure. Office Versus Home BP Statistically significant linear relationships were also documented between office SBP and ME average home SBP, morning home SBP, and evening home SBP (Figure 2) and the corresponding DBP values (Figure S2). Home BP values corresponding to different values for office BP were determined using a prediction equation calculated from Deming regression, and values are shown below each graph in Figure 2 (SBP) and Figure S2 (DBP). Deming regression between office SBP and home SBP (A, ME average; B, morning; and C, evening). Each horizontal line indicates the ambulatory SBP value corresponding to office SBP value in the same color based on the 2017 ACC/AHA guidelines. Red lines indicate office SBP: 80 mm Hg; ME average SBP, morning SBP, and evening SBP: 80 mm Hg. Blue lines indicate office SBP: 90 mm Hg; ME average SBP, morning SBP, and evening SBP: 85 mm Hg. Green lines indicate office SBP: 100 mm Hg; ME average SBP, morning SBP, and evening SBP: 90 mm Hg. *P<0.001. ACC indicates American College of Cardiology; AHA, American Heart Association; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; ME, morning‐evening; and SBP, systolic blood pressure. Home Versus Ambulatory BP There were also significant linear relationships between ME average home BP (SBP and DBP) and ambulatory BP parameters (24‐hour average and daytime and nighttime BP) (Figure 3 and Figure S3). Specific ambulatory BP values corresponding to ME average home SBP values of 120, 130, 135, and 140 mm Hg and ME average home DBP values of 80, 85, and 90 mm Hg, calculated from Deming regression, are shown below the graphs in Figure 3 (SBP) and Figure S3 (DBP). Deming regression between ME average SBP and ambulatory SBP (A, 24‐hour average; B, daytime; and C, nighttime). Each horizontal line indicates the ambulatory SBP value corresponding to office SBP value in the same color based on the ACC/AHA guidelines. Red lines indicate ME average SBP: 80 mm Hg; 24‐hour average SBP: 75 mm Hg; daytime SBP: 80 mm Hg; and nighttime SBP: 65 mm Hg. Blue lines indicate ME average SBP: 85 mm Hg; 24‐hour average SBP: 80 mm Hg; daytime SBP: 85 mm Hg; and nighttime SBP: 70 mm Hg. Green lines indicate office SBP: 90 mm Hg; 24‐hour average SBP: 90 mm Hg; daytime SBP: 90 mm Hg; and nighttime SBP: 85 mm Hg. *P<0.001. ACC indicates American College of Cardiology; AHA, American Heart Association; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; ME, morning‐evening; and SBP, systolic blood pressure. Sensitivity Analyses To simplify the relationship between BP indexes, the corresponding prediction equations generated from nonconstant Deming regressions are shown in Table S4. Similar results from Deming regression were found. The results from the Deming regressions in patient subgroups based on age (<65 versus ≥65 years) and sex are shown in Table S5. Ambulatory SBP values corresponding to an office SBP of 140 mm Hg were higher in men than in women and in those aged <65 versus ≥65 years. Home SBP values corresponding to an office SBP of 140 mm Hg were lower in patients aged <65 versus ≥65 years. Ambulatory SBP values corresponding to an ME average home SBP of 135 mm Hg were slightly higher in men than in women and in those aged <65 versus ≥65 years. In addition, a restricted cubic spline regression between office SBP and 24‐hour average SBP (A) and ME average SBP (B) is shown in Figure S4; there was no marked nonlinear relationship depending on BP levels. Ambulatory and Home BP Thresholds Compared With Current Guidelines Home BP and ambulatory BP values that corresponded with office BP values are summarized in Table 1. Thresholds based on the HI‐JAMP study results were approximated every 5 mm Hg from the results shown in Figures 1 and 2. In terms of relationship with office BP values, there was good agreement between home and ambulatory BP thresholds defined on the basis of the current analysis of baseline data from the HI‐JAMP study and those from the 2017 American College of Cardiology/American Heart Association (ACC/AHA) 5 and Japanese Society of Hypertension 2019 4 guidelines (Table 1). Agreement between values from the current analysis and the guidelines was best for ME average home BP, then 24‐hour and daytime ambulatory BP (Table 1). Table 1Ambulatory and Home BP Values Corresponding to Office BP ValuesOffice BP, mm HgThresholds based on HI‐JAMP study results, mm HgThresholds from the 2017 ACC/AHA guidelines, mm HgJSH 2019, mm HgHome BPAmbulatory BPHome BPAmbulatory BPHome BPME average24‐h AverageDaytimeNighttimeME average24‐h AverageDaytimeNighttimeME average120/80120*/75† 115*/75* 120*/75105/70120/80115/75120/80100/65115/75130/80130*/75† 120/75* 125/75110*/70130/80125/75130/80110/65125/75140/90135*, †/85*, † 130*/80* 135*/85* 120*/75135/85130/80135/85120/70135/85160/100145*, †/90*, † 140/85145*/90* 130/80145/90145/90145/90140/85145/90Ambulatory and home BP values that corresponded with office BP values based on data from the HI‐JAMP study were approximated every 5 mm Hg from the data in Figures 1 and 2. ACC/AHA indicates American College of Cardiology/American Heart Association; BP, blood pressure; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; JSH, Japanese Society of Hypertension; and ME, morning‐evening.*Same value as the 2017 ACC/AHA guidelines. † Same value as JSH 2019 guideline thresholds. Ambulatory and Home BP Values Corresponding to Office BP Values Ambulatory and home BP values that corresponded with office BP values based on data from the HI‐JAMP study were approximated every 5 mm Hg from the data in Figures 1 and 2. ACC/AHA indicates American College of Cardiology/American Heart Association; BP, blood pressure; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; JSH, Japanese Society of Hypertension; and ME, morning‐evening. Same value as the 2017 ACC/AHA guidelines. Same value as JSH 2019 guideline thresholds. Similarly, ambulatory BP values that corresponded with ME average home BP values are summarized in Table 2. Thresholds based on the HI‐JAMP study results were approximated every 5 mm Hg from the results shown in Figure 3. Looking at the relationship with ME average home BP, ambulatory BP thresholds determined in the current analysis also showed a good relationship with 2017 ACC/AHA 5 guidelines (Table 2). In particular, daytime ambulatory BP values based on HI‐JAMP study baseline data were identical to those in the current US guidelines (Table 2). In addition, at ME home BP values ≤135/85 mm Hg, 24‐hour ambulatory BP thresholds were also identical to those in the ACC/AHA guidelines (Table 2). Table 2Ambulatory BP Values Corresponding to Home BP ValuesHome BP ME average, mm HgThresholds based on HI‐JAMP study results, mm HgThresholds from the 2017 ACC/AHA guidelines, mm HgAmbulatory BPAmbulatory BP24‐h AverageDaytimeNighttime24‐h AverageDaytimeNighttime120/80115*/75* 120*/80* 100*/70115/75120/80100/65130/80125*/75* 130*/80* 115/70125/75130/80110/65135/85130*/80* 135*/85* 120*/75130/80135/85120/70145/90135/85145*/90* 130/80145/90145/90140/85Ambulatory and home BP values that corresponded with ME average home BP values based on data from the HI‐JAMP study were approximated every 5 mm Hg from the data in Figure 3. ACC/AHA indicates American College of Cardiology/American Heart Association; BP, blood pressure; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; and ME, morning‐evening.*Same value as the 2017 ACC/AHA guidelines. Ambulatory BP Values Corresponding to Home BP Values Ambulatory and home BP values that corresponded with ME average home BP values based on data from the HI‐JAMP study were approximated every 5 mm Hg from the data in Figure 3. ACC/AHA indicates American College of Cardiology/American Heart Association; BP, blood pressure; HI‐JAMP, Home‐Activity Information and Communication Technology–Based Japan Ambulatory Blood Pressure Monitoring Prospective; and ME, morning‐evening. Same value as the 2017 ACC/AHA guidelines. DISCUSSION This study used baseline data from the HI‐JAMP study that were obtained from the same validated device for measurement of office, home, and ambulatory BP plus Deming regression analysis to identify corresponding BP thresholds. The values obtained showed a good relationship that could be predicted using a simple equation and largely agreed well with the different BP thresholds described in current US and Japanese guidelines. 4 , 5 Furthermore, the findings of this analysis provide population‐specific values for home and ambulatory BP that correspond with office BP in Japanese individuals with treated hypertension. This, at least in part, addresses the unmet need for evaluation of the ABPM and HBPM thresholds corresponding to office BP in different racial and ethnic populations (and also patients from racial and ethnic minority groups). 21 In addition, the confirmation that BP thresholds in this Japanese population correspond to those in the ACC/AHA guidelines is consistent with the need for tighter control of BP over 24 hours in Asian populations. 22 , 23 The ACC/AHA guidelines used an outcomes‐based approach to determining the home and ambulatory BP thresholds corresponding to office BP levels because the guideline writing committee agreed that this was the best approach available at the time. 21 Although the current analysis did not use outcomes‐based methods to determine home and ambulatory BP thresholds, the values obtained using Deming regression were consistent with the values used in the ACC/AHA guidelines. ABPM is currently the gold standard BP assessment technique. At an office BP of 120/80, 130/80, or 140/90 mm Hg, corresponding 24‐hour ambulatory BP values based on the current analysis were 115/75, 120/75, and 140/90 mm Hg, respectively, which is highly consistent with the 2017 ACC/AHA guidelines. 5 This suggests that ambulatory BP values obtained using the all‐in‐one device could reliably be used to diagnose hypertension and facilitate its management with respect to treatment BP targets. HBPM has several advantages over ABPM, including wider availability, better patient acceptability and tolerability, and good reproducibility of BP phenotypes. 24 HBPM is therefore emerging as an important technique in the diagnosis and management of hypertension, especially as digital health strategies evolve and become increasingly used. 14 , 15 Similar to ABPM, the current analysis generated ME average home BP thresholds that were largely consistent with both the 2017 ACC/AHA 5 and 2019 Japanese Society of Hypertension 4 guidelines. Perhaps more important, this analysis showed that HBPM‐defined thresholds for the diagnosis of hypertension and for target BP during antihypertensive therapy corresponded well with thresholds defined using ABPM. In particular, Deming regression found that the ME average home SBP threshold was almost the same as the daytime ambulatory SBP threshold (home SBP=0.99×daytime ambulatory SBP+0.27 mm Hg; correlation coefficient r=0.627). Daytime ambulatory SBP values that corresponded with specific ME average home SBP levels of 120, 130, 135, and 145 mm Hg were 119.1, 129.0, 133.9, and 143.8 mm Hg, respectively. This finding is clinically relevant because HBPM is likely more accessible to patients, is probably cheaper, and can be more easily applied for widespread use in everyday practice than ABPM (but without any loss of diagnostic or therapeutic value based on current findings). Morning BP and the morning BP surge are important markers of cardiovascular risk in individuals with hypertension. 25 , 26 , 27 , 28 , 29 , 30 , 31 Data on these parameters are best obtained using HBPM. 30 A key strength of this study is that it is the first to use an all‐in‐one BP monitoring device to obtain values for office, home, and ambulatory BP. In addition, we used Deming regression, which is one of the recommended methods for estimating ABPM and HBPM values that correspond with a specific office BP value because this approach addresses error in the exposure variable. 21 However, some limitations of the current analysis need to be acknowledged. First, determination of home and ambulatory BP thresholds corresponding with specific office BP levels was not performed using an outcomes‐based approach, as used by the ACC/AHA guidelines. 21 However, Deming regression analysis was used, which is preferable to many other regression‐based approaches. 21 Second, this study only included patients with hypertension who were being treated with antihypertensive pharmacotherapy. Therefore, the results may not be generalized completely to untreated individuals with hypertension. In addition, morning home BP readings were taken before dosing of antihypertensive therapy, although this is consistent with current guideline recommendations. 4 Also with respect to BP measurements, the order of these was fixed by the study protocol (office BP, then ABPM, then HBPM), and the possibility that results may vary slightly if measurements were performed in a different order (eg, HBPM, then ABPM) cannot be excluded. Finally, the study population included only patients from Japan and, therefore, the applicability of the findings to populations residing in other locations is unknown. Therefore, additional studies are needed to replicate and extend the current findings in different patient groups and populations. CONCLUSIONS Appropriate HBPM and ABPM thresholds are important to allow the accurate diagnosis of hypertension, to determine whether target BP is being achieved during treatment, and therefore to determine when therapy intensification (or down‐titration) is required. In addition, the growing role of digital‐based strategies in hypertension relies on robust data from out‐of‐office BP monitoring, especially HBPM. The current findings, generated from office, home, and ambulatory BP data obtained using the same device, can be used to help define diagnostic and therapeutic BP levels for a home BP‐guided digital approach to hypertension management, especially in Japanese patients with treated hypertension. Sources of Funding This study was supported in part by funds from A&D Co, Ltd, and Otsuka Medical Devices Co, Ltd, and by a grant from the Foundation for the Development of the Community (Tochigi, Japan). Disclosures Dr Kario has received research grants from Omron Healthcare Co, Ltd, A&D Co, Ltd, and Fukuda Denshi Co, Ltd; and Dr Nishizawa has received honoraria for lectures from Daiichi‐Sankyo Co, Ltd, and Novartis Pharma K.K. The remaining authors have no disclosures to report. Supporting information Data S1 Tables S1–S5 Figures S1–S4 Click here for additional data file.